High-Dose Omega-3 vs Omega-6 Fats Shape Tumor Growth in Mouse Neuroblastoma Model
This laboratory study used a mouse model of neuroblastoma, an aggressive childhood cancer, to see how very high doses of omega-6 (arachidonic acid, ARA) versus omega-3 (DHA) fatty acids influenced tumor behavior.
Mice fed ultra-high doses of ARA developed tumors in 100% of cases, and those tumors grew roughly four times larger than controls. In contrast, mice fed ultra-high doses of DHA saw tumors shrink dramatically — about half fully regressed, and the rest grew to only a fraction of the size seen in controls or ARA-fed animals.
Using detailed lipid chemistry analysis, researchers found that ARA was converted into inflammatory signaling molecules (like PGE2 and TXB2) known to promote blood vessel growth and tumor spread. DHA, on the other hand, competed with ARA for these same enzymatic pathways and instead produced specialized pro-resolving lipid mediators associated with reduced inflammation and blood vessel formation.
What this means for you
This early-stage animal research suggests that the balance of omega-6 and omega-3 fats in the diet may influence biochemical pathways involved in tumor growth, at least in this specific mouse cancer model. It does not show that omega-3 supplements treat or prevent cancer in people, but it adds to scientific understanding of how dietary fats interact with inflammatory signaling pathways that are also relevant to general health.
Ready to start? The ALP Protocol delivers the EPA & DHA doses used in the research.
Start the ALP ProtocolSource
ACS pharmacology & translational science · 2026-09-11 · DOI: 10.1021/acsptsci.6c00098
Read the original source ↗This summary is for educational purposes only and is not medical advice. Always talk to your healthcare provider before making changes to your supplement routine.